Clinical Trials in Tennessee

Showing 2361-2380 of 17,345 trials

Veterans Coordinated Community Care (3C) Study

NCT05272176

Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after discharge. Outcomes include suicide-related behaviors (including deaths due to suicide, opioid overdose, or other substance-related accidents; and nonfatal suicide attempts) and suicidal ideation and functioning.

Suicide

Brown University850 participantsStarted Jan 2022

Little Rock, Arkansas, United States • Boston, Massachusetts, United States • Minneapolis, Minnesota, United States +4 more locations

COMPLETED29 miles

Artificial Urinary Sphincter Clinical Outcomes

NCT04088331

To evaluate the AMS 800 Artificial Urinary Sphincter (AUS) in men with primary stress urinary incontinence as measured by pad weight tests.

Stress Urinary Incontinence

Boston Scientific Corporation145 participantsStarted Oct 2019

San Francisco, California, United States • Aurora, Colorado, United States • Iowa City, Iowa, United States +15 more locations

Veterans Coordinated Community Care (3C) Study

Artificial Urinary Sphincter Clinical Outcomes

Find Trials by Condition in Tennessee

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Neural Correlates of Sensory Phenomena in Tourette Syndrome

Post Acute Sequelae of COVID-19

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Cerliponase Alfa Observational Study in the US

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Phase III Trial of Sirolimus in IBM